tiprankstipranks
Trending News
More News >
Quest Diagnostics (DGX)
NYSE:DGX
US Market
Advertisement

Quest Diagnostics (DGX) Earnings Dates, Call Summary & Reports

Compare
980 Followers

Earnings Data

Report Date
Jan 29, 2026
Before Open (Confirmed)
Period Ending
2025 (Q4)
Consensus EPS Forecast
2.36
Last Year’s EPS
2.23
Same Quarter Last Year
Moderate Buy
Based on 11 Analysts Ratings

Earnings Call Summary

Q3 2025
Earnings Call Date:Oct 21, 2025|
% Change Since:
|
Earnings Call Sentiment|Positive
The earnings call reflects strong performance in revenue growth, successful collaborations, and advances in diagnostics. However, the potential impact of PAMA reforms and higher operational costs present challenges.
Company Guidance
In the third quarter of 2025, Quest Diagnostics showed significant growth with revenues increasing by 13.1%, including 6.8% organic growth. The company reported consolidated revenues of $2.82 billion, with Diagnostic Information Services up by 13.5%. Total volume rose by 12.5%, and organic volume by 3.9%. The revenue per requisition increased by 0.8%, while the organic revenue per requisition was up 3%. Operating income on a reported basis was $386 million, representing 13.7% of revenues, whereas the adjusted operating income was $458 million or 16.3% of revenues. Reported EPS was $2.16, and adjusted EPS was $2.60. Quest Diagnostics also updated its full-year 2025 guidance, expecting revenues between $10.96 billion and $11 billion, with adjusted EPS ranging from $9.76 to $9.84, and cash from operations anticipated to be approximately $1.8 billion. The company highlighted strong demand in its clinical solutions, successful acquisitions, and key partnerships, including a joint venture with Corewell Health and collaborations with consumer health brands such as WHOOP and OURA.
Strong Revenue Growth
Quest Diagnostics reported a 13.1% increase in revenues, with 6.8% organic growth driven by the adoption of clinical innovations and contributions from acquisitions.
Successful Collaborations and Ventures
The company announced a joint venture with Corewell Health to form a lab services joint venture in Michigan and several partnerships with consumer health brands like WHOOP and OURA Health.
Advanced Diagnostics Expansion
Quest Diagnostics experienced double-digit revenue growth in advanced diagnostics, particularly in areas like cardiometabolic, autoimmune, and brain health.
Cash Flow and Financial Performance
Cash from operations increased by 63.1% year-to-date, driven by higher operating income and favorable working capital.
Raised Full-Year Guidance
The company raised its full-year 2025 guidance, expecting revenues between $10.96 billion and $11 billion, and adjusted EPS between $9.76 and $9.84.

Quest Diagnostics (DGX) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

DGX Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Jan 29, 2026
2025 (Q4)
2.36 / -
2.23
Oct 21, 2025
2025 (Q3)
2.50 / 2.60
2.313.04% (+0.30)
Jul 22, 2025
2025 (Q2)
2.57 / 2.62
2.3511.49% (+0.27)
Apr 22, 2025
2025 (Q1)
2.15 / 2.21
2.048.33% (+0.17)
Jan 30, 2025
2024 (Q4)
2.19 / 2.23
2.153.72% (+0.08)
Oct 22, 2024
2024 (Q3)
2.26 / 2.30
2.223.60% (+0.08)
Jul 23, 2024
2024 (Q2)
2.33 / 2.35
2.32.17% (+0.05)
Apr 23, 2024
2024 (Q1)
1.86 / 2.04
2.040.00% (0.00)
Feb 01, 2024
2023 (Q4)
2.11 / 2.15
1.988.59% (+0.17)
Oct 24, 2023
2023 (Q3)
2.19 / 2.22
2.36-5.93% (-0.14)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

DGX Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Oct 21, 2025
$190.41$184.64-3.03%
Jul 22, 2025
$165.71$177.45+7.08%
Apr 22, 2025
$160.42$171.30+6.78%
Jan 30, 2025
$153.30$161.91+5.62%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Quest Diagnostics (DGX) report earnings?
Quest Diagnostics (DGX) is schdueled to report earning on Jan 29, 2026, Before Open (Confirmed).
    What is Quest Diagnostics (DGX) earnings time?
    Quest Diagnostics (DGX) earnings time is at Jan 29, 2026, Before Open (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is DGX EPS forecast?
          DGX EPS forecast for the fiscal quarter 2025 (Q4) is 2.36.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis